Cargando…

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Lung cancer is the second-most commonly diagnosed cancer and the leading cause of cancer death worldwide. The most common histological type is non-small-cell lung cancer, accounting for 85% of all lung cancer cases. About one out of three new cases of non-small-cell lung cancer are diagnosed at a lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrella, Francesco, Rizzo, Stefania, Attili, Ilaria, Passaro, Antonio, Zilli, Thomas, Martucci, Francesco, Bonomo, Luca, Del Grande, Filippo, Casiraghi, Monica, De Marinis, Filippo, Spaggiari, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047909/ https://www.ncbi.nlm.nih.gov/pubmed/36975452 http://dx.doi.org/10.3390/curroncol30030239

Ejemplares similares

Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
por: Attili, Ilaria, et al.
Publicado: (2020)

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Mohamed, Shehab, et al.
Publicado: (2023)

Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung Cancer: A 20-Year Single-Center Retrospective Study
por: Casiraghi, Monica, et al.
Publicado: (2023)

Current Perspectives in Mesenchymal Stromal Cell Therapies for Airway Tissue Defects
por: Petrella, Francesco, et al.
Publicado: (2015)

Preliminary Results of Robotic Lobectomy in Stage IIIA-N2 NSCLC after Induction Treatment: A Case Control Study
por: Casiraghi, Monica, et al.
Publicado: (2021)

Prognostic Value of Red Blood Cell Distribution Width in Resected pN1 Lung Adenocarcinoma
por: Petrella, Francesco, et al.
Publicado: (2020)

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology
por: de Marinis, Filippo, et al.
Publicado: (2022)

Surgical Approaches to Pancoast Tumors
por: Petrella, Francesco, et al.
Publicado: (2023)

The “Balloon-Like” Sign: Differential Diagnosis between Postoperative Air Leak and Residual Pleural Space: Radiological Findings and Clinical Implications of the Young–Laplace Equation
por: Petrella, Francesco, et al.
Publicado: (2022)

CT-Derived Body Composition Values and Complications After Pneumonectomy in Lung Cancer Patients: Time for a Sex-Related Analysis?
por: Rizzo, Stefania, et al.
Publicado: (2022)

The Role of Surgery in High-Grade Neuroendocrine Cancer: Indications for Clinical Practice
por: Petrella, Francesco, et al.
Publicado: (2022)

Prognostic Value of the Hemoglobin/Red Cell Distribution Width Ratio in Resected Lung Adenocarcinoma
por: Petrella, Francesco, et al.
Publicado: (2021)

State of the art and new perspectives in surgical treatment of lung cancer: a narrative review
por: Petrella, Francesco, et al.
Publicado: (2022)

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence
por: Attili, Ilaria, et al.
Publicado: (2022)

Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model
por: de Marinis, Filippo, et al.
Publicado: (2020)

Incidental diagnosis of pulmonary mycobacteriosis among patients scheduled for lung cancer surgery: results from a series of 3224 consecutive operations
por: Petrella, Francesco, et al.
Publicado: (2019)

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
por: Passaro, Antonio, et al.
Publicado: (2021)

The Impact of Multidisciplinary Team Meetings on Patient Management in Oncologic Thoracic Surgery: A Single-Center Experience
por: Petrella, Francesco, et al.
Publicado: (2021)

Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery
por: Petrella, Francesco, et al.
Publicado: (2017)

Understanding EGFR heterogeneity in lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020)

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations
por: Attili, Ilaria, et al.
Publicado: (2023)

erbB in NSCLC as a molecular target: current evidences and future directions
por: Del Re, Marzia, et al.
Publicado: (2020)

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
por: Spitaleri, Gianluca, et al.
Publicado: (2023)

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
por: Spitaleri, Gianluca, et al.
Publicado: (2023)

Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer
por: Galetta, Domenico, et al.
Publicado: (2022)

ARDS after Pneumonectomy: How to Prevent It? Development of a Nomogram to Predict the Risk of ARDS after Pneumonectomy for Lung Cancer
por: Mazzella, Antonio, et al.
Publicado: (2022)

The Role of Surgery in Primary Chest Wall Tumors: Over 20 Years’ Experience in Resection and Reconstruction
por: Lo Iacono, Giorgio, et al.
Publicado: (2023)

Unplanned Return to the Operating Room after Elective Oncologic Thoracic Surgery: A Further Quality Indicator in Surgical Oncology
por: Petrella, Francesco, et al.
Publicado: (2022)

Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
por: Guarize, Juliana, et al.
Publicado: (2021)

Association of a CT-Based Clinical and Radiomics Score of Non-Small Cell Lung Cancer (NSCLC) with Lymph Node Status and Overall Survival
por: Botta, Francesca, et al.
Publicado: (2020)

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%
por: Attili, Ilaria, et al.
Publicado: (2022)

Bronchopleural fistula treatment: From the archetype of surgery to the future of stem cell therapy
por: Petrella, Francesco, et al.
Publicado: (2015)

Computed Tomography–Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis
por: Del Grande, Maria, et al.
Publicado: (2021)

Editorial: Strategies of Lymph Node Dissection During Sublobar Resection for Early Stage Lung Cancer
por: Casiraghi, Monica, et al.
Publicado: (2022)

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey
por: Catania, Chiara, et al.
Publicado: (2020)

Long-Term Outcomes of Robotic-Assisted, Video-Assisted and Open Surgery in Non-Small Cell Lung Cancer: A Matched Analysis
por: Casiraghi, Monica, et al.
Publicado: (2022)

Next-Generation Lung Cancer Surgery: A Brief Trip into the Future of the Research
por: Uslenghi, Clarissa, et al.
Publicado: (2023)

Surgical management of superior sulcus tumors: A twenty-year experience of an oncological high volume referral centre
por: Bertolaccini, Luca, et al.
Publicado: (2023)

Endobronchial Ultrasound Transbronchial Needle Aspiration in Thoracic Diseases: Much More than Mediastinal Staging
por: Guarize, Juliana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1qem425i4n27rgjfeqsc2e7lrv